Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading - MarketWatch

1. Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading  MarketWatch
2. US approves fish oil-based drug for cutting heart risks  Yahoo Lifestyle
3. Amarin Stock Remains Halted After FDA Approves Vascepa In Cardiovascular Risk  Investor's Business Daily
4. FDA approves first fish-oil drug for cutting cardiac risks  NBCNews.com
5. FDA Approves Fish-Oil-Derived Drug for Use Preventing Heart Attacks, Strokes  The Wall Street Journal
6. View full coverage on Google News

Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading - MarketWatch
Read More


Bagikan Berita Ini